Here's The Last Biotech Breakout

Until the markets pullback a bit, investors and traders will ride this gravy train as long as it goes. Thanks to the market run-up a lot of stocks already seem somewhat extended. However, there are some stocks that are a little late to the party and are just now breaking higher.

For example, Celldex Therapeutics, Inc. CLDX just recently broke out above its $18 resistance. In that period of time that stock has already hit a high of over $21.

Another biotech name that just broke out this week, and whose chart looks very similar to Celldex, would be XOMA.

The company: XOMA Corp

Ticker Symbol: XOMA

Sector: Healthcare

Industry: Biotechnology

XOMA discovers and develops antibody-based therapeutics in the United States, Europe, and the Asia Pacific.

Related Link: This Biotech Stock Is Ready To Run

The company’s proprietary products include XOMA metabolic activating, sensitizing, and antagonizing/deactivating antibodies that are in preclinical stage for the treatment of diabetes patients, a multi-antibody product for the treatment of human botulism poisoning, and a topical anti-bacterial product for the treatment of human immune system.

Review the one-year chart of XOMA with the added notations:

After losing more than 60 percent of its value, XOMA finally found a bottom in May near $3.50 per share.

Since that bottom, the stock has been trading in a well-defined range between a low of around $3.60 and a topside resistance at $5. This sideways range appears to have been a basing process for XOMA.

Earlier this week XOMA broke through its $5 resistance and did so with a large increase in volume. High volume may add validity to a breakout.

When stocks form XOMA’s type of pattern and breakout, higher prices overall could be expected.

The stock closed Tuesday at $5.52.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: Long IdeasShort IdeasHealth CareTechnicalsTrading IdeasGeneralFive Star Stock Watch
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!